Article Text

FRI0457 Recommendations for The Management of Comorbidities in Psoriatic Disease
  1. J.C. Torre-Alonso1,
  2. L. Carmona2,
  3. M. Moreno3,
  4. E. Galíndez4,
  5. J. Babío5,
  6. P. Zarco6,
  7. L.F. Linares7,
  8. E. Collantes8,
  9. M. Fernández-Barrial9,
  10. J.C. Hermosa10,
  11. P. Coto11,
  12. C. Suárez12,
  13. R. Almodόvar6,
  14. J. Luelmo13,
  15. V. Cárcaba11,
  16. S. Castañeda14,
  17. J. Gratacόs3
  1. 1Rheumatology, Hospital Virgen del Naranco, Oviedo
  2. 2Instituto de Salud Musculoesquelética, Madrid
  3. 3Rheumatology, Hospital Universitari Parc Taulí, Sabadell
  4. 4Rheumatology, H. Universitario Basurto, Bilbao
  5. 5Rheumatology, H. Cabueñes, Gijόn
  6. 6Rheumatology, H. Fundaciόn Alcorcόn, Madrid
  7. 7Rheumatology, H. Virgen de la Arrixaca, Murcia
  8. 8Rheumatology, H. Reina Sofía, Cόrdoba
  9. 9C.S. de Sotondrio, Langreo
  10. 10C.S. de Getafe, Madrid
  11. 11Dermatology, H. U. Central de Asturias, Oviedo
  12. 12Internal Medicine, H. U. de la Princesa, IIS-Princesa, Madrid
  13. 13Dermatology, Hospital Universitari Parc Taulí, Sabadell
  14. 14Rheumatology, H. U. de la Princesa, IIS-Princesa, Madrid, Spain


Objectives To establish recommendations for the management of comorbidities in patients with psoriatic disease (PsD).

Methods A multidisciplinary panel drafted the recommendationsin a nominal group session. Evidence from four systematic reviews was added. Agreement was assessed by two-rounds Delphi technique. Recommendations with an agreement ≥7/10 by at least 70% of participants were kept in.

Results A total of 19 recommendations on three key topics were issued: 1) screening of specific comorbidities, 2) specific preventive or therapeutic actions, and 3) general management.

Table 1

Conclusions Disease control coupled with the management of comorbidities is critical to ensure optimal patient care. These recommendations suggest actions on detection, management and integration of care in PsD.

Acknowledgement GECOAP project was funded by Merck Sharp & Dohme of Spain

Disclosure of Interest None declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.